(HealthDay)—The NephroCheck test, designed to predict the risk of sudden kidney injury within 12 hours, has been approved by the U.S. Food and Drug Administration.
Sep 5, 2014
0
0
(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...
Sep 21, 2012
0
0
(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.
Dec 4, 2017
0
0
(HealthDay) -- Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release.
Mar 2, 2012
0
0
(HealthDay)—Trying to calm a cranky baby can be stressful for parents, but the U.S. Food and Drug Administration has an important caution about what not to do.
Sep 5, 2019
0
0
The Federal Aviation Administration briefly suspended flights to New York City-area airports on Saturday because of coronavirus-related staffing issues as the number of confirmed cases in New York state soared above 10,000.
Mar 21, 2020
0
1
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher ...
Jun 2, 2013
0
0
(HealthDay)—Two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved by the U.S. Food and Drug Administration to treat advanced melanoma, the most dangerous form of skin cancer.
May 29, 2013
0
0
Each year, many people look forward to ringing in the new year with family and friends. However, some celebrations include the combination of alcohol and late-night driving—which can lead to fatal accidents.
Dec 28, 2022
0
11
Ocular Systems, Inc. (OSI), Wake Forest Baptist Medical Center and the North Carolina Eye Bank have formed a new company based on a promising new technology aimed at engineering replacement corneas in the lab for transplantation.
Jan 8, 2013
0
0
